📊 BLND Key Takeaways
Investment Thesis
Blend Labs demonstrates strong gross margins (73.8%) indicating viable unit economics, but is burdened by significant operating losses (-17.6% margin) and negative stockholders' equity (-$30.5M), signaling structural profitability challenges despite 6.8% revenue growth. The company is burning cash operationally while consuming nearly all free cash flow, and the combination of negative equity with ongoing losses presents material solvency risk.
BLND Strengths
- Strong gross margin of 73.8% demonstrates underlying product value and pricing power
- Positive operating cash flow of $11.5M despite negative net income shows some business resilience
- Revenue growth of 6.8% YoY indicates market demand for services
- Adequate liquidity with current ratio of 2.48x and $43.6M cash reserves
BLND Risks
- Negative stockholders' equity of -$30.5M indicates liabilities exceed assets and represents existential solvency risk
- Persistent operating losses (-$21.7M) and negative net margin (-5.5%) show inability to convert revenue to profitability at scale
- Free cash flow nearly breakeven (-$81K) with capex consuming all operating cash, leaving no margin for safety or investment
- Operating margin deterioration relative to gross margin suggests cost structure problems in sales, general, and administrative functions
Key Metrics to Watch
- Path to operating profitability - whether company can reduce operating expenses to achieve positive EBITDA
- Free cash flow trajectory - must turn positive and sustain without requiring external capital
- Stockholders' equity recovery - need to see deficit eliminated through operations or capital raises
- Operating margin expansion - gap between 73.8% gross margin and -17.6% operating margin must narrow significantly
BLND Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.48x current ratio provides a solid financial cushion.
BLND Profitability Ratios
BLND vs Technology Sector
How Blend Labs, Inc. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BLND Balance Sheet & Liquidity
BLND 5-Year Financial Trend
5-Year Trend Summary: Blend Labs, Inc.'s revenue has declined by 47% over the 5-year period, indicating business contraction. The most recent EPS of $-0.76 indicates the company is currently unprofitable.
BLND Growth Metrics (YoY)
BLND Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $32.9M | -$2.4M | $0.02 |
| Q2 2025 | $28.7M | -$6.6M | N/A |
| Q1 2025 | $23.8M | -$9.2M | N/A |
| Q3 2024 | $40.6M | -$2.4M | $-0.03 |
| Q2 2024 | $40.5M | -$19.4M | $-0.09 |
| Q1 2024 | $34.9M | -$20.7M | $-0.09 |
| Q3 2023 | $40.6M | -$41.2M | $-0.18 |
| Q2 2023 | $42.8M | -$41.2M | $-0.18 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BLND Capital Allocation
BLND SEC Filings
Access official SEC EDGAR filings for Blend Labs, Inc. (CIK: 0001855747)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BLND
What is the AI rating for BLND?
Blend Labs, Inc. (BLND) has an AI rating of SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BLND's key strengths?
Strong gross margin of 73.8% demonstrates underlying product value and pricing power. Positive operating cash flow of $11.5M despite negative net income shows some business resilience.
What are the risks of investing in BLND?
Negative stockholders' equity of -$30.5M indicates liabilities exceed assets and represents existential solvency risk. Persistent operating losses (-$21.7M) and negative net margin (-5.5%) show inability to convert revenue to profitability at scale.
What is BLND's revenue and growth?
Blend Labs, Inc. reported revenue of $123.6M.
Does BLND pay dividends?
Blend Labs, Inc. does not currently pay dividends.
Where can I find BLND SEC filings?
Official SEC filings for Blend Labs, Inc. (CIK: 0001855747) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BLND's EPS?
Blend Labs, Inc. has a diluted EPS of $-0.10.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.